FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: INTERNATIONAL DRUG SCHEDULING; SINGLE CONVENTION ON NARCOTIC DRUGS; CONVENTION ON PSYCHOTROPIC SUBSTANCES; CLOBROMAZOLAM (PHENAZOLAM); CYCHLORPHINE (N-PROPIONITRILE CHLORPHINE); DESALKYLGIDAZEPAM (BROMONORDIAZEPAM); ETHYLBROMAZOLAM; ETOMETHAZENE (5-METHYL ETODESNITAZENE); SPIROCHLORPHINE (R6980); ETOMIDATE; MEDETOMIDINE; REQUEST FOR COMMENTS

WASHINGTON, Aug. 26 -- Food and Drug Administration has issued a notice called: International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments.

The notice was published in the Federal Register on Aug. 26 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit comments concerning abuse potential, actual abuse,...